These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 3083075

  • 21. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
    McVerry BA, Machin SJ, Galloway MJ, McCarthy K, Evans P, Barnes RM, Turner GC, Cheingsong-Popov R, Tedder RS, Winter M.
    Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
    [Abstract] [Full Text] [Related]

  • 22. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
    Biagiotti R, Giudizi MG, Almerigogna F, Mazzetti M, Alessi A, Del Prete GF, Rafanelli D, Fiorilli M, Morfini M, Romagnani S.
    Clin Exp Immunol; 1986 Feb; 63(2):354-8. PubMed ID: 3009063
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P, Mariani G, Mannucci PM, De Rossi G, Nicoletti L, Titti F, Falcione E, Pasqualetti D, Ammassari M, Gringeri A.
    J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
    [Abstract] [Full Text] [Related]

  • 24. Relation of human T lymphotropic virus type III antibodies to T lymphocyte subset abnormalities in hemophiliac patients.
    Hoxie JA, Rackowski JL, Cedarbaum AJ, Hurwitz S, Catalano PM.
    Am J Med; 1986 Aug; 81(2):201-7. PubMed ID: 3017105
    [Abstract] [Full Text] [Related]

  • 25. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
    Volsky DJ, Wu YT, Sinangil F, Goldsmith JC.
    AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of HTLV-III antibody among New Mexico residents with hemophilia.
    Waskin H, Smith KJ, Simon TL, Gribble TJ, Mertz GJ.
    West J Med; 1986 Oct; 145(4):477-80. PubMed ID: 3641500
    [Abstract] [Full Text] [Related]

  • 27. Generalized lymphadenopathy and T cell abnormalities in hemophilia A.
    Gill JC, Menitove JE, Wheeler D, Aster RH, Montgomery RR.
    J Pediatr; 1983 Jul; 103(1):18-22. PubMed ID: 6223133
    [Abstract] [Full Text] [Related]

  • 28. Humoral and cellular immune abnormalities in adult hemophiliacs followed over a 2-year period.
    Freedman J, Mazaheri R, Read S, Garvey MB, Teitel J.
    Diagn Clin Immunol; 1987 Jul; 5(1):30-40. PubMed ID: 2439226
    [Abstract] [Full Text] [Related]

  • 29. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL, Gomperts ED, McDougal JS, Ramsey RB.
    N Engl J Med; 1985 Feb 21; 312(8):483-6. PubMed ID: 2982095
    [Abstract] [Full Text] [Related]

  • 30. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development.
    Orgad S, Malone G, Zaizov R, Marinowitz U, McLane MF, Umiel T, Cohen IJ, Vogel R, Cohen-Avishai O, Ramot B.
    AIDS Res Hum Retroviruses; 1987 Feb 21; 3(3):323-32. PubMed ID: 3124874
    [Abstract] [Full Text] [Related]

  • 31. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
    Knutsen AP, Bouhasin JD, Lawrence DN, Roodman ST, Mueller KR, McDougal JS, Joist JH.
    Ann Allergy; 1986 Nov 21; 57(5):376-84. PubMed ID: 2946253
    [Abstract] [Full Text] [Related]

  • 32. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B, Klose HJ, Gürtler L, Eberle J, Deinhardt F, Köhler-Vajta K, Peller P.
    Thromb Haemost; 1986 Aug 20; 56(1):50-2. PubMed ID: 3095947
    [Abstract] [Full Text] [Related]

  • 33. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JK, Dixon G, Doxey M, Evatt BL.
    JAMA; 1985 Jun 21; 253(23):3409-15. PubMed ID: 2987559
    [Abstract] [Full Text] [Related]

  • 34. 1986 update of HIV seroprevalence, seroconversion, AIDS incidence, and immunologic correlates of HIV infection in patients with hemophilia A and B.
    Ragni MV, Winkelstein A, Kingsley L, Spero JA, Lewis JH.
    Blood; 1987 Sep 21; 70(3):786-90. PubMed ID: 2887224
    [Abstract] [Full Text] [Related]

  • 35. Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III).
    Horsburgh CR, Davis KC, Hasiba U, Weiss SH, Goedert JJ, Sarin P, Kirkpatrick CH.
    J Clin Immunol; 1986 Jan 21; 6(1):37-42. PubMed ID: 3007563
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antibodies to human T-cell lymphotropic virus-I membrane antigens and inverted T4/T8 ratios in hemophiliacs.
    Kloster BE, Tomar RH, Stockman JA, Lamberson HV, Merl SA, John PA, Groth DM, Poiesz BJ.
    Am J Clin Pathol; 1985 Apr 21; 83(4):450-6. PubMed ID: 2984918
    [Abstract] [Full Text] [Related]

  • 39. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
    Stein SF, Evatt BL, McDougal JS, Lawrence DN, Holman RC, Ramsey RB, Spira TJ.
    Blood; 1985 Oct 21; 66(4):973-9. PubMed ID: 2994784
    [Abstract] [Full Text] [Related]

  • 40. HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort.
    Simmonds P, Lainson FA, Cuthbert R, Steel CM, Peutherer JF, Ludlam CA.
    Br Med J (Clin Res Ed); 1988 Feb 27; 296(6622):593-8. PubMed ID: 3126920
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.